Hypertension drug developer Mineralys Therapeutics files for $100M IPO


Initial Public Offering. IPO. Financial trade. Investment

Andranik Hakobyan

Hypertension drug developer Mineralys Therapeutics (MLYS) has filed for a $100M initial public offering.

The biotech company didn’t specify in its filing the price or number of shares to be offered, but indicated in its filing



Source link